We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

48 hedge funds and large institutions have $18.2M invested in Achieve Life Sciences in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $71K | Put options by funds: $32K

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

1% less capital invested

Capital invested by funds: $18.4M → $18.2M (-$259K)

2% less funds holding

Funds holding: 49 → 48 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
14
Reduced
13
Closed
9
Calls
$71K
Puts
$32K
Net Calls
+$39K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$461K
2
TC
TFS Capital
Pennsylvania
+$446K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$258K
4
Deutsche Bank
Deutsche Bank
Germany
+$253K
5
BIT
BlackRock Institutional Trust
California
+$159K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$1.35M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$794K
3
BI
BVF Inc
California
-$784K
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$198K
5
BIM
Bogle Investment Management
Massachusetts
-$187K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$96K -$9.92K -2 -10%
Morgan Stanley
27
Morgan Stanley
New York
$91K -$9.92K -2 -10%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$85K -$24.8K -5 -23%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$84K +$4.96K +1 +7%
Millennium Management
30
Millennium Management
New York
$81K +$79.4K +16 New
Goldman Sachs
31
Goldman Sachs
New York
$79K +$9.92K +2 +14%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$69K – – –
CAM
33
ClariVest Asset Management
California
$64K – – –
Two Sigma Advisers
34
Two Sigma Advisers
New York
$59K -$39.7K -8 -42%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$56K – – –
Bank of America
36
Bank of America
North Carolina
$50K – – –
Bank of New York Mellon
37
Bank of New York Mellon
New York
$44K +$4.96K +1 +13%
OC
38
Oppenheimer & Co
New York
$35K +$34.7K +7 New
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$32K +$29.8K +6 New
RCM
40
Rotella Capital Management
Washington
$27K +$24.8K +5 New
State Street
41
State Street
Massachusetts
$24K -$4.96K -1 -17%
Citigroup
42
Citigroup
New York
$24K – – –
TH
43
Timber Hill
Connecticut
$23K – – –
BJ
44
BlackRock Japan
Japan
$12K -$9.92K -2 -50%
BIM
45
BlackRock Investment Management
Delaware
$9K – – –
TWA
46
TCI Wealth Advisors
Arizona
$9K +$9.92K +2 New
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$3K +$4.96K +1 New
UBS Group
48
UBS Group
Switzerland
$3K +$4.96K +1 New
AIG
49
American International Group
New York
$2.33K – – –
Group One Trading
50
Group One Trading
Illinois
$2K – – –
1
2
3

ACHV Hedge Fund Activity: Q2 2015 in Review

48 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2015, worth a combined $18.2M — down 1.4% from $18.4M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ACHV and 8 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 14 added.

The largest buyer was Renaissance Technologies, adding an estimated $461K. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.35M sold.

  • 48 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2015, down from 49 in Q1 2015.
  • Funds reported $18.2M of Achieve Life Sciences stock for Q2 2015, down 1.4% quarter-over-quarter.
  • 8 funds opened new Achieve Life Sciences positions in Q2 2015 and 9 closed out, a net change of -1 holder.
  • The largest Achieve Life Sciences buyer in Q2 2015 was Renaissance Technologies, an estimated $461K added.
  • The largest Achieve Life Sciences seller in Q2 2015 was Tang Capital Management, an estimated $1.35M sold.

Based on aggregated 13F filings for Q2 2015.